Notwithstanding the relationship between PPARα activity and hepatic lipid metabolism, studies of PPARα expression levels in patients with steatosis or NASH are conflicting, reporting unchanged, increased and decreased PPARα expression 38, 39. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatohepatitis.